Clinical Cancer Research CR Surrogrates Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, R.
Right arrow Articles by Vessella, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, R.
Right arrow Articles by Vessella, R. L.
Clinical Cancer Research Vol. 6, 1140-1149, March 2000
© 2000 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Differential Expression of Osteonectin/SPARC during Human Prostate Cancer Progression1

Regi Thomas2, Lawrence D. True, James A. Bassuk, Paul H. Lange and Robert L. Vessella

Departments of Urology [R. T., J. A. B., P. H. L., R. L. V.] and Pathology [L. D. T.], University of Washington, Seattle, Washington 98195

The precise mechanism(s) involved in invasion and metastasis of prostate cancer (CaP) is poorly understood. Osteonectin [ON (also known as SPARC or BM-40)] is an antiadhesive protein known to be involved in cell-matrix interactions, migration, and angiogenesis. In this report, we studied the expression of ON in human prostate cell lines, primary tumors, and metastatic foci of CaP. Reverse transcription-PCR and nonradioactive in situ hybridization (ISH) techniques were used to determine ON gene expression. Immunohistochemistry was carried out using the polyclonal antibody LF37 and/or the monoclonal antibody ON-mAb. Low to moderate levels of ON mRNA and protein were observed in glandular epithelial cells of normal tissue as well as a few primary CaPs. However, high levels of ON mRNA and protein were observed in most of the CaP metastatic foci, both osseous and nonosseous. This correlated well with our findings that multiple different CaP cell lines including four CaP cell lines derived from metastases show high levels of ON gene expression. Furthermore, ISH analyses and cell-specific reverse transcription-PCR evaluation showed that both the luminal and basal cells express the ON gene. We conclude that the differential pattern of ON expression suggests that it may play an important role in the progression of CaP.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
K. Chu, C.-J. Cheng, X. Ye, Y.-C. Lee, A. J. Zurita, D.-T. Chen, L.-Y. Yu-Lee, S. Zhang, E. T. Yeh, M. C-T. Hu, et al.
Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone
Mol. Cancer Res., August 1, 2008; 6(8): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Chen, X.-C. Ye, K. Chu, N. M. Navone, E. H. Sage, L.-Y. Yu-Lee, C. J. Logothetis, and S.-H. Lin
A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells
Cancer Res., July 15, 2007; 67(14): 6544 - 6548.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
P. Qiu, Z. J. Wang, K. J. R. Liu, Z.-Z. Hu, and C. H. Wu
Dependence network modeling for biomarker identification
Bioinformatics, January 15, 2007; 23(2): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Handayani, L. Rice, Y. Cui, T. A. Medrano, V. G. Samedi, H. V. Baker, N. J. Szabo, and K. T. Shiverick
Soy Isoflavones Alter Expression of Genes Associated with Cancer Progression, Including Interleukin-8, in Androgen-Independent PC-3 Human Prostate Cancer Cells
J. Nutr., January 1, 2006; 136(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Ikuta, T. Nakatsura, T. Kageshita, S. Fukushima, S. Ito, K. Wakamatsu, H. Baba, and Y. Nishimura
Highly Sensitive Detection of Melanoma at an Early Stage Based on the Increased Serum Secreted Protein Acidic and Rich in Cysteine and Glypican-3 Levels
Clin. Cancer Res., November 15, 2005; 11(22): 8079 - 8088.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. W. Nyman, K. J. Campbell, E. Hersh, K. Long, K. Richardson, V. Trieu, N. Desai, M. J. Hawkins, and D. D. Von Hoff
Phase I and Pharmacokinetics Trial of ABI-007, a Novel Nanoparticle Formulation of Paclitaxel in Patients With Advanced Nonhematologic Malignancies
J. Clin. Oncol., November 1, 2005; 23(31): 7785 - 7793.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. N. Rich, C. Hans, B. Jones, E. S. Iversen, R. E. McLendon, B.K. A. Rasheed, A. Dobra, H. K. Dressman, D. D. Bigner, J. R. Nevins, et al.
Gene Expression Profiling and Genetic Markers in Glioblastoma Survival
Cancer Res., May 15, 2005; 65(10): 4051 - 4058.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-C. Huang, Z. Xie, H. Konaka, J. Sodek, H. E. Zhau, and L. W.K. Chung
Human Osteocalcin and Bone Sialoprotein Mediating Osteomimicry of Prostate Cancer Cells: Role of cAMP-Dependent Protein Kinase A Signaling Pathway
Cancer Res., March 15, 2005; 65(6): 2303 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. S. Parker, P. Argani, B. P. Cook, H. Liangfeng, S. D. Chartrand, M. Zhang, S. Saha, A. Bardelli, Y. Jiang, T. B. St. Martin, et al.
Alterations in Vascular Gene Expression in Invasive Breast Carcinoma
Cancer Res., November 1, 2004; 64(21): 7857 - 7866.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. I. Koukourakis, A. Giatromanolaki, R. A. Brekken, E. Sivridis, K. C. Gatter, A. L. Harris, and E. H. Sage
Enhanced Expression of SPARC/Osteonectin in the Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Correlated with Markers of Hypoxia/ Acidity and with Poor Prognosis of Patients
Cancer Res., September 1, 2003; 63(17): 5376 - 5380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. Rich, Q. Shi, M. Hjelmeland, T. J. Cummings, C.-T. Kuan, D. D. Bigner, C. M. Counter, and X.-F. Wang
Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model
J. Biol. Chem., April 25, 2003; 278(18): 15951 - 15957.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Inoue, A. Matsuyama, K. Mimori, H. Ueo, and M. Mori
Prognostic Score of Gastric Cancer Determined by cDNA Microarray
Clin. Cancer Res., November 1, 2002; 8(11): 3475 - 3479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bagai, E. Rubio, J.-F. Cheng, R. Sweet, R. Thomas, E. Fuchs, R. Grady, M. Mitchell, and J. A. Bassuk
Fibroblast Growth Factor-10 Is a Mitogen for Urothelial Cells
J. Biol. Chem., June 21, 2002; 277(26): 23828 - 23837.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Prakash, G. Pirozzi, M. Elashoff, W. Munger, I. Waga, R. Dhir, Y. Kakehi, and R. H. Getzenberg
Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays
PNAS, May 28, 2002; 99(11): 7598 - 7603.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Sturm, K. Satyamoorthy, F. Meier, B. B. Gardiner, D. J. Smit, B. Vaidya, and M. Herlyn
Osteonectin/SPARC Induction by Ectopic {beta}3 Integrin in Human Radial Growth Phase Primary Melanoma Cells
Cancer Res., January 1, 2002; 62(1): 226 - 232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. A. Gmyrek, M. Walburg, C. P. Webb, H.-M. Yu, X. You, E. D. Vaughan, G. F. Vande Woude, and B. S. Knudsen
Normal and Malignant Prostate Epithelial Cells Differ in Their Response to Hepatocyte Growth Factor/Scatter Factor
Am. J. Pathol., August 1, 2001; 159(2): 579 - 590.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
G. K. Yiu, W. Y. Chan, S.-W. Ng, P. S. Chan, K. K. Cheung, R. S. Berkowitz, and S. C. Mok
SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells
Am. J. Pathol., August 1, 2001; 159(2): 609 - 622.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.